Research has revealed that O-GlcNAc modification enhances AKT activity, promoting tumor cell proliferation and survival (51); O-GlcNAc modification strengthens the stability of HIF-1α, promoting tumor cell angiogenesis and metastasis (52). The gene discussed is AKT1; the disease is neoplasm.